The FDA has added a new black box warning to Xeloda, a cancer drug which may increase the risk of bleeding when used with certain blood thinners.
Tag Archives: Cancer Drug
An FDA advisory committee voted to recommend the agency not approve Copiktra for some blood cancer patients due to an increased risk of death.
An advisory committee is being asked to review the benefits and risks of Copiktra, a blood cancer drug FDA experts say appears to lower life expectancy in some cancer patients.
The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.
More Top Stories
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.
A $479 million Philips CPAP class action settlement agreement will resolve claims of economic loss filed by users of the recalled devices.